🇺🇸 FDA
Pipeline program

PCSK9 inhibitor

sICASBLM

Unknown small_molecule active

Quick answer

PCSK9 inhibitor for Intracranial Artery Stenosis is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Intracranial Artery Stenosis
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials